Lutathera 370 MBq/mL solution for infusion, LysaKare 25 g/25 g solution for infusion
PROICM 2021-04 REL
Phase 2 small_molecule active
Quick answer
Lutathera 370 MBq/mL solution for infusion, LysaKare 25 g/25 g solution for infusion for Neuroendocrine tumor is a Phase 2 program (small_molecule) at Institut für biomedizinische Analytik NMR-Imaging GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Institut für biomedizinische Analytik NMR-Imaging GmbH
- Indication
- Neuroendocrine tumor
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active